http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf591b48c3eeffb6eb3cbaec9176908d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Halle |
| name | Mari K Halle Mari K. Halle |
| given-name | Mari K Mari K. |
| organization-name | Authors' Affiliations: 1Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Department of Epidemiology, Shanghai Cancer Institute; 3Shanghai Institute of Preventive Medicine, Shanghai, China; 4Division of Genetics and Population Health, Queensland Institute of Medical Research, 5Cancer Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; 6Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge; 7Wellcome Trust Centre for Human Genetics and NIHR Comprehensive Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; 8Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut; 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 10Division Gynaecological Oncology, Katholieke Universit; Authors' Affiliations: 1Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Department of Epidemiology, Shanghai Cancer Institute; 3Shanghai Institute of Preventive Medicine, Shanghai, China; 4Division of Genetics and Population Health, Queensland Institute of Medical Research, 5Cancer Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; 6Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge; 7Wellcome Trust Centre for Human Genetics and NIHR Comprehensive Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; 8Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut; 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 10Division Gynaecological Oncology, Katholieke Universit 3Centre for Cancer Biomarkers, Department of Clinical Science, The University of Bergen, Bergen, Norway.; 4Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. Department of Obstetrics and Gynecology Haukeland University Hospital Bergen Norway; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science University of Bergen Bergen Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway Authors' Affiliations: 1Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Department of Epidemiology, Shanghai Cancer Institute; 3Shanghai Institute of Preventive Medicine, Shanghai, China; 4Division of Genetics and Population Health, Queensland Institute of Medical Research; 5Cancer Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane Queensland, Australia; 6Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge; 7Wellcome Trust Centre for Human Genetics and NIHR Comprehensive Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; 8Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut; 9Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Belgium; 10Gynaecology Research Unit, Hannover Medical Sch; Authors' Affiliations: 1Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Department of Epidemiology, Shanghai Cancer Institute; 3Shanghai Institute of Preventive Medicine, Shanghai, China; 4Division of Genetics and Population Health, Queensland Institute of Medical Research; 5Cancer Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane Queensland, Australia; 6Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge; 7Wellcome Trust Centre for Human Genetics and NIHR Comprehensive Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; 8Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut; 9Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Belgium; 10Gynaecology Research Unit, Hannover Medical Sch Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway Center for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway 1Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway. Authors' Affiliations: Departments of 1Health Sciences Research, Division of Epidemiology, 2Medical Oncology, 3Health Sciences Research, Division of Biomedical Statistics and Informatics, 4Immunology, and 5Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; 6Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida; 7Channing Division of Network Medicine, 8Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School; 9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 10Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; 11Department of Clinical Science, University of Bergen; Departments of 12Gynecology and Obstetrics, and 13Pathology, Haukeland University Hospital, Bergen, Norway; Departments for 14Health Evidence, 15Urology, and 16Gynaecology, Radboud University Medical Centre, Nijmegen; 17; Authors' Affiliations: Departments of 1Health Sciences Research, Division of Epidemiology, 2Medical Oncology, 3Health Sciences Research, Division of Biomedical Statistics and Informatics, 4Immunology, and 5Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; 6Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida; 7Channing Division of Network Medicine, 8Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School; 9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 10Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; 11Department of Clinical Science, University of Bergen; Departments of 12Gynecology and Obstetrics, and 13Pathology, Haukeland University Hospital, Bergen, Norway; Departments for 14Health Evidence, 15Urology, and 16Gynaecology, Radboud University Medical Centre, Nijmegen; 17 Department of Clinical Science, Centre for Cancer Biomarkers University of Bergen Bergen Norway; Department of Obstetrics and Gynaecology Haukeland University Hospital Bergen Norway |
Incoming Links
Showing number of triples: 1 to 52 of 52.